Related references
Note: Only part of the references are listed.Epstein-Barr Virus and Neurological Diseases
Nan Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics
Myat Noe Han et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches
Marija Vidovic et al.
CELLS (2022)
Porphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?
Dongcheng Li et al.
FRONTIERS IN NEUROLOGY (2022)
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis
Ting Shen et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Amanda L. Miller et al.
FRONTIERS IN IMMUNOLOGY (2021)
Periodontal Inflammation and Systemic Diseases: An Overview
Mireya Martinez-Garcia et al.
FRONTIERS IN PHYSIOLOGY (2021)
Humoral Response to Microbial Biomarkers in Rheumatoid Arthritis Patients
Seyedesomaye Jasemi et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Microbial Infections Are a Risk Factor for Neurodegenerative Diseases
Sarah K. Lotz et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
A Possible Role for HSV-1-Specific Humoral Response and PILRA rs1859788 Polymorphism in the Pathogenesis of Parkinson's Disease
Simone Agostini et al.
VACCINES (2021)
HERV-W and Mycobacterium avium subspecies paratuberculosis Are at Play in Pediatric Patients at Onset of Type 1 Diabetes
Marta Noli et al.
PATHOGENS (2021)
Persistent Bacteriuria and Antibodies Recognizing Curli/eDNA Complexes FromEscherichia coliAre Linked to Flares in Systemic Lupus Erythematosus
Ryan J. Pachucki et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis
Chandran Ramakrishna et al.
PLOS ONE (2020)
Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
Stephen S. Dominy et al.
SCIENCE ADVANCES (2019)
Exploring the Multiple-Hit Hypothesis of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat
Kristin L. Patrick et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Serotype b of Aggregatibacter actinomycetemcomitans triggers pro-inflammatory responses and amyloid beta secretion in hippocampal cells: a novel link between periodontitis and Alzheimer′s disease?
J. Diaz-Zuniga et al.
JOURNAL OF ORAL MICROBIOLOGY (2019)
Curli-Containing Enteric Biofilms Inside and Out: Matrix Composition, Immune Recognition, and Disease Implications
Sarah A. Tursi et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2018)
Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response
Vincent Blasco-Baque et al.
GUT (2017)
Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease
E. Caggiu et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Links between atherosclerotic and periodontal disease
Dimitry A. Chistiakov et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?
Giannina Arru et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Epstein Barr Virus and Mycobacterium avium subsp paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients
Giuseppe Mameli et al.
SCIENTIFIC REPORTS (2016)
Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein
John Woulfe et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Gastrointestinal dysfunction in Parkinson's disease
Alfonso Fasano et al.
LANCET NEUROLOGY (2015)
Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker
Naomi P. Visanji et al.
MOVEMENT DISORDERS (2014)
Hypothesis: A role for EBV-induced molecular mimicry in Parkinson's disease
John M. Woulfe et al.
PARKINSONISM & RELATED DISORDERS (2014)
Periodontal Treatment Decreases Levels of Antibodies to Porphyromonas gingivalis and Citrulline in Patients With Rheumatoid Arthritis and Periodontitis
Moe Okada et al.
JOURNAL OF PERIODONTOLOGY (2013)
α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
Lynnae M. Smith et al.
PLOS ONE (2012)
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Kiran Yanamandra et al.
PLOS ONE (2011)
Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms
Cagla Tukel et al.
CELLULAR MICROBIOLOGY (2010)
Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group
Melissa K. Tuck et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment
N. Makiura et al.
ORAL MICROBIOLOGY AND IMMUNOLOGY (2008)
Plasma α-synuclein is decreased in subjects with Parkinson's disease
Qiao-Xin Li et al.
EXPERIMENTAL NEUROLOGY (2007)